← SynDRA
EMEDASTINE
SynDRA canonical compound SYN0001033 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Histamine H1 Receptor Antagonists
- Histamine-1 Receptor Inhibitor
- Anti-Allergic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
ATC classes
- S01G · DECONGESTANTS AND ANTIALLERGICS
Cross-references
Synonyms
- EMADINE
- emedastine difumarate ophthalmic solution
- emedastine fumarate
- emadine
- emedastine difumarate
- daren
- Emedastina
- Emadine
- Emedastinum
- Emedastine [INN]
- Emedastine difumarate
- KB-2413
- KG-2413
- Emadine (TN)
- Emedastina [INN-Spanish]
- Emedastine (INN)
- Emedastine [INN:BAN]
- Emedastinum [INN-Latin]
- 9J1H7Y9OJV
- CHEBI:4779
- RefChem:590745
- DTXCID8028218
- S01GX06
- C17H26N4O
- NCGC00181341-01
- UNII-9J1H7Y9OJV
- Emedastine?
- MFCD00865647
- Emedastine (Standard)
- Emedastine Impurity 14
- EMEDASTINE [MI]
- EMEDASTINE [VANDF]
- EMEDASTINE [WHO-DD]
- SCHEMBL29770
- EMEDASTINE [EMA EPAR]
- GTPL7174
- orb1303482
- SCHEMBL29493445
Look up EMEDASTINE in the interactive SynDRA portal →